SRPT vs STOK · rev $1.13B vs rev $15.6M
Sarepta Therapeutics Inc (SRPT) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
SRPT currently screens at market cap $2.34B. STOK currently screens at market cap $1.88B.
Not investment advice. Open the SRPT and STOK stock pages for the full models.
Not investment advice.